We are live on
!
Find out more
Nuvation Bio
NUVB
NUVB
116 hedge funds and large institutions have $204M invested in Nuvation Bio in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
600% more call options, than puts
Call options by funds: $7K | Put options by funds: $1K
30% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 33
11% more capital invested
Capital invested by funds: $183M → $204M (+$20.5M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.84% less ownership
Funds ownership: 62.53% → 61.69% (-0.84%)
7% less funds holding
Funds holding: 125 → 116 (-9)
39% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 23
Holders
116
Holders Change
-9
Holders Change %
-7.2%
% of All Funds
1.69%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
14
Increased
43
Reduced
33
Closed
23
Calls
$7K
Puts
$1K
Net Calls
+$6K
Net Calls Change
-$150K
Top Buyers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$4.5M |
| 2 |
Millennium Management
New York
|
+$2.21M |
| 3 |
Morgan Stanley
New York
|
+$1.49M |
| 4 |
Renaissance Technologies
New York
|
+$1.41M |
| 5 |
Citigroup
New York
|
+$1.36M |
